Ticagrelor versus clopidogrel in <i>CYP2C19</i> loss-of-function carriers with stroke or TIA stratified by age and renal function: CHANCE-2 trial substudy.

Ticagrelor 與 clopidogrel 在帶有 CYP2C19 功能喪失基因、依年齡及腎功能分層之中風或短暫性腦缺血發作（TIA）患者的比較：CHANCE-2 試驗次分析